78 related articles for article (PubMed ID: 1017536)
1. The epidemiology of hyperlipoproteinemia in a Rumanian general population sample. Study of 7,085 cases.
Mincu I; Ionescu-Tîrgoviste C; Stanescu J; Boboia D; Cheta D; Popa E; Mihalache N; Georgescu M
Diabete Metab; 1976 Dec; 2(4):171-82. PubMed ID: 1017536
[TBL] [Abstract][Full Text] [Related]
2. [Changes in serum lipoproteins in patients with ischemic heart disease at an early age].
Malamov E; Kiriakov A; Tsenov I; Kavrukova Iu; Kusitasev G
Vutr Boles; 1982; 21(2):91-8. PubMed ID: 7101895
[TBL] [Abstract][Full Text] [Related]
3. [Fenofibrate: hypolipaemic activity and safety in long-term treatment. Effects on HDL, LDL, VLDL and apoprotein B in short-term treatment (author's transl)].
Rouffy J; Sauvanet JP; Chanu B; Bakir R; Goy-Loeper J; Saya C; Pinaroli F
Nouv Presse Med; 1980 Dec; 9(49):3747-51. PubMed ID: 7208341
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis of primary hyperlipoproteinemia during a preventive examination].
Raslová K; Mongiellová V; Hucková M
Cas Lek Cesk; 1993 Mar; 132(5):137-41. PubMed ID: 8472293
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
6. [Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis].
Jäger E; Sinzinger H; Widhalm K; Kaliman J; Höfer R
Wien Klin Wochenschr; 1982 Sep; 94(16):421-5. PubMed ID: 7147981
[TBL] [Abstract][Full Text] [Related]
7. [Blood lipid patterns in a population over 65 years of age in the Val d'Aosta area].
Angelico F; Galante A; Pennetti V
G Ital Cardiol; 1976; 6(6):1015-23. PubMed ID: 1022601
[TBL] [Abstract][Full Text] [Related]
8. [Effect of 1 month's treatment with Bezalip on the serum lipids and lipoproteins of patients with different types of hyperlipoproteinemias].
Kiriakov A; Malamov E; Apostolova Iu; Tsenov I; Tinterova Z
Vutr Boles; 1983; 22(3):74-81. PubMed ID: 6649587
[TBL] [Abstract][Full Text] [Related]
9. [The relation between lipoprotein fractions, sex and IHD in patients with primary hyperlipoproteinemia].
Hora C; Hanefeld M; Leonhardt W; Jacob F; Haller H
Z Gesamte Inn Med; 1982 Dec; 37(23):801-4. PubMed ID: 7164523
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hyperlipoproteinemia, types II and IV, with pirifibrate: one hundred observations.
Bonora V; Calalabuig RJ; Caviola E; Soler J; Pueyo JM; Micaló T; Cano RP
Clin Ther; 1981; 4(3):192-200. PubMed ID: 7030489
[TBL] [Abstract][Full Text] [Related]
11. Pirifibrate in the treatment of hyperlipoproteinemias: a multicenter study.
Domingo AJ; Gutiérrez JA; Menéndez JA; Micó L; Muñoz M; de Oya M
Clin Ther; 1980; 3(3):219-26. PubMed ID: 7459931
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of hyperlipoproteinaemia in vascular disease.
Lawrie TD; Lorimer AR; Ballantyne D; Jubb JS; Morgan HG
Postgrad Med J; 1975; 51(8):suppl 7-15. PubMed ID: 215984
[TBL] [Abstract][Full Text] [Related]
13. Studies in asymptomatic primary hyperlipidaemia II. Clinical findings.
Olsson AG
Acta Med Scand; 1975 Jun; 197(6):477-85. PubMed ID: 168737
[TBL] [Abstract][Full Text] [Related]
14. Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV.
Lopez Rodriguez J; Martorell J
Clin Ther; 1980; 3(4):234-41. PubMed ID: 7273061
[TBL] [Abstract][Full Text] [Related]
15. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and biochemical features of atherosclerosis main risk factors in children of probands with primary hyperlipidemia].
Alidzhanova KhG; Tvorogova MG; Rozhkova TA; Balakhonova TV; Vorob'eva LP; Masenko VP; Kukharchuk VV
Ter Arkh; 1998; 70(1):19-23. PubMed ID: 9532645
[TBL] [Abstract][Full Text] [Related]
17. Dietary control of hyperlipoproteinemia.
Lacatîs D; Bălan M; Creţeanu G
Med Interne; 1980; 18(1):49-53. PubMed ID: 7375800
[TBL] [Abstract][Full Text] [Related]
18. Blood plasma apolipoproteins A-I and B in different types of hyperlipoproteinaemia: comparative analysis of population groups in Moscow and Prague.
Metel'skaya VA; Ceska R; Perova NV; Sobra J
Cor Vasa; 1988; 30(3):168-76. PubMed ID: 3139364
[TBL] [Abstract][Full Text] [Related]
19. Detection of dyslipoproteinemia with the use of plasma total cholesterol and triglyceride as screening tests. The Lipid Research Clinics Program Prevalence Study.
Kwiterovich PO; Stewart P; Probstfield JL; Stinnett S; Chambless LE; Chase GA; Jacobs DR; Morrison JA
Circulation; 1986 Jan; 73(1 Pt 2):I30-9. PubMed ID: 3940681
[TBL] [Abstract][Full Text] [Related]
20. Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyperlipoproteinemia;
Einarsson K; Hellström K; Kallner M
J Clin Invest; 1974 Dec; 54(6):1301-11. PubMed ID: 4373491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
